Infraredi

Infraredi sells LED-based red-light and near-infrared therapy devices for home use, organized into compact panels, modular “stack” systems, and targeted wands. Prices run AUD 249–1,499, situating the brand in the mid-range of the consumer photobiomodulation market. All sales are direct-to-consumer through infraredi.com and the company’s Amazon Australia store; no physical retail network is operated. The line is distinguished by medical-grade 660 nm & 850 nm dual-chip LEDs, flicker-free drivers, and a modular rail system that lets users link multiple panels without tools. Every device is listed as an ARTG-approved Class IIa medical device (ARTG 373970) and ships with adjustable stands, eye protection, and treatment protocols devised by an in-house physiotherapist. The brand’s best-known SKUs are the Infraredi Pro Max 2.0 and the Flex Mid 2.0, both marketed for skin, muscle-recovery, and joint applications. Core buyers are 30-55-year-old Australians who already spend on bio-hacking, functional fitness, or chronic-pain management and want clinic-grade irradiance without ongoing appointment costs. The brand voice stresses science-backed dosage, safety certification, and local customer support, aligning with value-driven consumers who research specifications and prefer modular upgrades over single-purpose gadgets. Infraredi competes with imported red-light panels sold on Amazon and with higher-priced North-American clinic brands. It differentiates by combining ARTG registration, local warranty/service hubs in Sydney and Melbourne, and mid-tier pricing that undercuts premium medical suppliers while offering higher irradiance and modular scalability than budget private-label sellers.